These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 2214148

  • 1. [Diagnosis: tumor marker].
    Inaba N, Takamizawa Y, Ota J, Fukazawa K.
    Gan No Rinsho; 1990 Aug; 36(10):1123-7. PubMed ID: 2214148
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Diagnostic significance of tumor markers for gynecologic malignancies].
    Aoki D, Hirasawa A, Susumu N.
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Development and clinical research of computer aided multivariate pattern analysis system (CAMPAS) OV-1 for diagnosis of ovarian carcinoma].
    Kobayashi S, Murae M, Kimura E.
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Mar; 45(3):241-8. PubMed ID: 8492011
    [Abstract] [Full Text] [Related]

  • 9. Tumor markers for the diagnosis, prognosis, treatment and follow-up of gynaecological tumors.
    Ulsperger E, Karrer K.
    Bull Soc Sci Med Grand Duche Luxemb; 1989 Mar; 126(1):33-43. PubMed ID: 2545372
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A, Caciagli M, Zampieri F, Ciampalini G, Carpi A, Spisni R, Colizzi C.
    Cancer Detect Prev; 1995 Mar; 19(2):183-95. PubMed ID: 7750106
    [Abstract] [Full Text] [Related]

  • 13. Biochemical prognostic factors and risk of relapses in patients with cervical cancer.
    Gadducci A, Tana R, Fanucchi A, Genazzani AR.
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S23-6. PubMed ID: 17727924
    [Abstract] [Full Text] [Related]

  • 14. [Tumor markers in gynecological and breast cancer].
    Jobo T, Sato R, Kuramoto H.
    Rinsho Byori; 2003 Dec; 51(12):1188-94. PubMed ID: 14743742
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [CEA monitoring of gynecologic tumor patients using a simplified CEA-radioimmunoassay].
    Hörst M, Wiest W.
    Fortschr Med; 1982 Mar 18; 100(11):482-3. PubMed ID: 7076078
    [No Abstract] [Full Text] [Related]

  • 20. [Cytokeratin tumor markers in ovarian carcinoma: tissue polypeptide specific antigen (TPS) and M3/M21].
    Hefler L, Tempfer C, Häusler G, Heinzl H, Kainz C.
    Wien Klin Wochenschr; 1998 Oct 02; 110(18):635-41. PubMed ID: 9816636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.